LINC02371

Across TCGA pan-cancer cohorts, LINC02371 RNA is linked to patient survival in 23 of 34 cancer types, making it the most broadly survival-associated LINC02371 data layer.

The strongest signal is observed in colon adenocarcinoma (COAD), where higher LINC02371 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated LINC02371 expression acts as an unfavorable survival marker, although some lineages such as PAAD and LGG show a favorable association.

COAD, PAAD, and HNSC are the cancer types where LINC02371 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
COAD	OS	Tertile	All	0.487	0.662	<.001	116	view →
PAAD	DFS	Tertile	All	0.497	0.261	<.001	53	view →
HNSC	OS	Median	II,III,IV	0.259	0.498	.001	53	view →
LGG	OS	Median	All	0.938	0.851	<.001	32	view →
UVM	DFS	Quartile	III,IV	0.339	0.739	.010	31	view →
UCEC	DFS	Tertile	All	0.512	0.701	<.001	30	view →
LUSC	OS	Median	II,III,IV	0.300	0.516	<.001	28	view →
THCA	OS	Tertile	II,III,IV	0.550	1.000	.013	25	view →
ACC	DFS	Median	III,IV	0.276	0.749	.003	25	view →
UCS	DFS	Tertile	IV	0.875	0.364	.024	24	view →
SKCM	DFS	Tertile	All	0.791	0.685	.007	19	view →
BLCA	DFS	Median	II,III,IV	0.411	0.270	.006	19	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 23 lineages.

LINC02371–COAD (OS)

Open the COAD breakdown →